Sophie Desmonde1, Jean-Bosco Essanin, Addi E Aka, Eugène Messou, Madeleine Amorissani-Folquet, Virginie Rondeau, Andrea Ciaranello, Valériane Leroy. 1. *Center INSERM U897, Epidémiologie Biostatistiques, Bordeaux, France; †Université Bordeaux, ISPED, Center INSERM U897, Epidémiologie Biostatistiques, Bordeaux, France; ‡Université de Cocody, Abidjan, Côte d'Ivoire; §CePReF, ACONDA, Abidjan Côte d'Ivoire; ‖Department of Pediatrics, Cocody University Hospital, Abidjan, Côte d'Ivoire; and ¶Massachusetts General Hospital, Boston, MA.
Abstract
BACKGROUND: We describe severe morbidity and health care resource utilization (HCRU) among HIV-infected children on antiretroviral therapy (ART) in Abidjan, Côte d'Ivoire. METHODS: All HIV-infected children enrolled in an HIV-care program (2004-2009) were eligible for ART initiation until database closeout, death, ART interruption, or loss to follow-up. We calculated incidence rates (IRs) of density per 100 child-years (CYs) for severe morbidity, HCRU (outpatient care and inpatient care), and associated factors using frailty models with a Weibull distribution. RESULTS: Of 332 children with a median age of 5.7 years and median follow-up of 2.5 years, 65.4% were severely immunodeficient by World Health Organization (WHO) criteria, and all received cotrimoxazole prophylaxis. We recorded 464 clinical events in 228 children; the overall IR was 57.6/100 CYs [95% confidence interval (CI): 52.1 to 62.5]. Severe morbidity was more frequent in children on protease inhibitor (PI)-based ART compared to those on other regimens [adjusted hazards ratio (aHR): 1.83; 95% CI: 1.35 to 2.47] and to those moderately/severely immunodeficient compared to those not (aHR: 1.57; 95% CI: 1.13 to 2.18 and aHR: 2.53; 95% CI: 1.81 to 3.55, respectively). Of the 464 events, 371 (80%) led to outpatient care (IR: 45.6/100 CYs) and 164 (35%) to inpatient care (IR: 20.2/100 CYs). In adjusted analyses, outpatient care was significantly less frequent in children older than 10 years compared with children younger than 2 years (aHR: 0.49; 95% CI: 0.31 to 0.78) and in those living furthest from clinics compared with those living closest (aHR: 0.65; 95% CI: 0.47 to 0.90). Both inpatient and outpatient HCRU were negatively associated with cotrimoxazole prophylaxis. CONCLUSIONS: Despite ART, HIV-infected children still require substantial utilization of health care services.
BACKGROUND: We describe severe morbidity and health care resource utilization (HCRU) among HIV-infectedchildren on antiretroviral therapy (ART) in Abidjan, Côte d'Ivoire. METHODS: All HIV-infectedchildren enrolled in an HIV-care program (2004-2009) were eligible for ART initiation until database closeout, death, ART interruption, or loss to follow-up. We calculated incidence rates (IRs) of density per 100 child-years (CYs) for severe morbidity, HCRU (outpatient care and inpatient care), and associated factors using frailty models with a Weibull distribution. RESULTS: Of 332 children with a median age of 5.7 years and median follow-up of 2.5 years, 65.4% were severely immunodeficient by World Health Organization (WHO) criteria, and all received cotrimoxazole prophylaxis. We recorded 464 clinical events in 228 children; the overall IR was 57.6/100 CYs [95% confidence interval (CI): 52.1 to 62.5]. Severe morbidity was more frequent in children on protease inhibitor (PI)-based ART compared to those on other regimens [adjusted hazards ratio (aHR): 1.83; 95% CI: 1.35 to 2.47] and to those moderately/severely immunodeficient compared to those not (aHR: 1.57; 95% CI: 1.13 to 2.18 and aHR: 2.53; 95% CI: 1.81 to 3.55, respectively). Of the 464 events, 371 (80%) led to outpatient care (IR: 45.6/100 CYs) and 164 (35%) to inpatient care (IR: 20.2/100 CYs). In adjusted analyses, outpatient care was significantly less frequent in children older than 10 years compared with children younger than 2 years (aHR: 0.49; 95% CI: 0.31 to 0.78) and in those living furthest from clinics compared with those living closest (aHR: 0.65; 95% CI: 0.47 to 0.90). Both inpatient and outpatient HCRU were negatively associated with cotrimoxazole prophylaxis. CONCLUSIONS: Despite ART, HIV-infectedchildren still require substantial utilization of health care services.
Authors: Mwangelwa Mubiana-Mbewe; Carolyn Bolton-Moore; Yolan Banda; Namwinga Chintu; Mutinta Nalubamba-Phiri; Mark Giganti; M Brad Guffey; Pauline Sambo; Elizabeth M Stringer; Jeffrey S A Stringer; Benjamin H Chi Journal: Trop Med Int Health Date: 2009-08-25 Impact factor: 2.622
Authors: C C Onyenekwe; N Ukibe; S C Meludu; A Ilika; N Aboh; N Ofiaeli; M Ezaeni; A Onochie Journal: J Vector Borne Dis Date: 2007-12 Impact factor: 1.688
Authors: Johan van Griensven; Ludwig De Naeyer; Jeanine Uwera; Anita Asiimwe; Claire Gazille; Tony Reid Journal: BMC Pediatr Date: 2008-10-02 Impact factor: 2.125
Authors: Mary B Morris; Bushimbwa Tambatamba Chapula; Benjamin H Chi; Albert Mwango; Harmony F Chi; Joyce Mwanza; Handson Manda; Carolyn Bolton; Debra S Pankratz; Jeffrey S A Stringer; Stewart E Reid Journal: BMC Health Serv Res Date: 2009-01-09 Impact factor: 2.655
Authors: Sophie Desmonde; Anne M Neilan; Beverly Musick; Gabriela Patten; Kulkanya Chokephaibulkit; Andrew Edmonds; Stephany N Duda; Karen Malateste; Kara Wools-Kaloustian; Andrea L Ciaranello; Mary-Ann Davies; Valériane Leroy Journal: J Int AIDS Soc Date: 2020-10 Impact factor: 5.396